About
- About us
  We add value to our customers through our vertically integrated supply chain ensuring unmatched quality and controlled processes.
- col-2
- col-3
Products
- Our Products
  Discover the latest in our research and development, product launches, and global outreach initiatives.
- col-2
- col-3
News
Careers
Contact
Copay Card

Currently Browsing

Product News

Aurobindo Pharma Ltd.’s ANDA 205835 for Meropenem for Injection was approved on 27 Mar. 2017 by US FDA.

Published: March 28, 2017

AuroMedics, a subsidiary of Aurobindo, will commence marketing the product in April 2017.